ex-vivo expanded allogeneic gamma delta T-cell therapy (Beijing 302 Hospital/Beijing GD Initiative Cell Therapy Technology Co.)

N/A

Report date: 2025/06/11 10:49:27

Base Information

Drug Nameex-vivo expanded allogeneic gamma delta T-cell therapy (Beijing 302 Hospital/Beijing GD Initiative Cell Therapy Technology Co.)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapy
Mechanisms of ActionImmunomodulatorsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNo 302 Hospital Of The People Liberation Army Of China
China Registration ClassN/A

Develop Information

Active CompaniesNo 302 Hospital Of The People Liberation Army Of ChinaBeijing GD Initiative Cell Therapy Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A